Found 7 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years - 80 years
All genders
Phase 2
Interventional
This study investigates the effects of an investigational medication compared to a placebo in adults with high-risk asthma. The purpose of this study is to evaluate how well the investigational medication works, as well as its safety and tolerability, when added to the current treatment of asthma. Participants in this …
18 years or above
All genders
Phase 4
Interventional
This study investigates the effects of an investigational medication on preventing or slowing lung function decline in adults with uncontrolled moderate to severe asthma. Participants in this study will be randomly assigned to one of two study arms: one receiving the investigational medication and the other receiving standard care therapy.Participants …
12 years or above
All genders
Phase 2
Interventional
This study investigates the safety and efficacy of an investigational medication for individuals aged 12 and older with moderate to severe atopic dermatitis. The study aims to understand how this medication affects participants over a long-term period.Participants will receive the investigational medication through injections under the skin. This open-label study …
18 years or above
All genders
Phase 2
Interventional
This study investigates the long-term safety and effects of an investigational medication in adults with asthma. The purpose of this study is to evaluate how safe and effective the investigational medication is for adults who have completed previous related studies.Participants in the study will continue their treatment with the investigational …
18 years or above
All genders
Phase 3
Interventional
This study investigates the long-term safety and tolerability of an investigational medication in adults with different forms of multiple sclerosis, including relapsing MS (RMS), primary progressive MS (PPMS), and non-relapsing secondary progressive MS (NRSPMS).Participants in this study will continue to receive the investigational medication in an open-label format, meaning both …
18 years - 55 years
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication compared to an existing treatment in adults with relapsing forms of multiple sclerosis (RMS). The study aims to measure the annualized relapse rate (ARR) in participants aged 18 to 55 years, using the investigational medication and comparing it to a daily …
All genders
Observational
This study investigates the clinical outcomes of patients with Gaucher disease. The study is observational, meaning it collects data from patients receiving routine care without altering their treatment. It aims to enhance understanding of the disease's variability, progression, and natural history to aid in better therapeutic interventions.Participants will undergo clinical …